Related Experiment Video
Updated: Jun 14, 2026
08:49
Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Surgery for intestinal Crohn's disease recurrence.
Antoine Brouquet1, Benjamin Blanc, Frederic Bretagnol
1Department of Colorectal Surgery, Beaujon Hospital, University Paris VII, Paris, France.
Surgery
|April 6, 2010
Summary
Reoperation for Crohn's disease (CD) recurrence is more complex than primary resection, leading to higher morbidity and longer hospital stays. Considering a temporary stoma is recommended for these patients.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Inflammatory Bowel Disease Research
Background:
- Crohn's disease (CD) recurrence often necessitates reoperation, which is perceived as more challenging than initial surgeries.
- Understanding postoperative outcomes after CD recurrence surgery is crucial for patient management.
Purpose of the Study:
- To evaluate the postoperative course and complications following reoperation for Crohn's disease recurrence.
- To compare morbidity between reoperation for CD recurrence and primary ileocolonic resections.
Main Methods:
- A cohort of 61 patients undergoing reoperation for CD recurrence (1998-2008) was analyzed.
- Risk factors for postoperative morbidity and major complications were assessed.
- A case-matched study compared 54 reoperations with 57 primary ileocolonic resections.
Main Results:
- No postoperative mortality was observed.
- Overall postoperative complications occurred in 38% of patients, with major complications in 10%.
- Reoperation group showed significantly higher morbidity (P = .0006), increased risk of intra-abdominal abscess (P = .007), and longer hospital stay (9 vs 7 days; P < .001).
Conclusions:
- Reoperation for CD recurrence is complex, often requiring additional procedures due to disease severity and adhesions.
- Reoperation is associated with higher morbidity and prolonged hospitalization compared to primary resection.
- Systematic consideration of a temporary defunctioning stoma is advised for patients undergoing reoperation for CD recurrence.
More Related Videos
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...